[Application of MR/PET in oncologic imaging].

No abstract is available for this paper.

• Publication year

  2012

• Venue

  RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1055/s-0031-1299334PMID 22618473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• F 18-FDG-PET / CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma

  2013cited by this paper
• Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.

  2012cited by this paper
• PET and PET-CT of lung cancer.

  2011cited by this paper
• 18F-FDG PET/CT of cervical carcinoma.

  2011cited by this paper
• Predictive Value of Initial 18F-FLT Uptake in Patients with Aggressive Non-Hodgkin Lymphoma Receiving R-CHOP Treatment

  2011cited by this paper
• 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation

  2011cited by this paper
• The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

  2011cited by this paper
• Non-small cell lung carcinoma: accuracy of PET/CT in determining the size of T1 and T2 primary tumors.

  2011cited by this paper
• Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.

  2011cited by this paper
• Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.

  2011cited by this paper
• Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma

  2011cited by this paper
• Design and performance evaluation of a whole-body Ingenuity TF PET–MRI system

  2011cited by this paper
• F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.

  2011cited by this paper
• PET-CT in preoperative staging of lung cancer.

  2011cited by this paper
• Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards.

  2011cited by this paper
• The effect of errors in segmented attenuation maps on PET quantification.

  2011cited by this paper
• PET and PET-CT in esophageal and gastric cancer.

  2011cited by this paper
• Feasibility of simultaneous PET/MR imaging in the head and upper neck area

  2011cited by this paper
• FDG-PET/CT in lymphoma.

  2011cited by this paper
• Integrating imaging modalities: what makes sense from a workflow perspective?

  2010cited by this paper
• A systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?

  2010cited by this paper
• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Diffusion Tensor Imaging in a Human PET/MR Hybrid System

  2010cited by this paper
• Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma

  2010cited by this paper
• Repeat FDG-PET for predicting pathological tumor response and prognosis after neoadjuvant treatment in nonsmall cell lung cancer: comparison with computed tomography.

  2010cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT

  2010cited by this paper
• Switching on the Lights for Real-Time Multimodality Tumor Neuroimaging: The Integrated Positron-Emission Tomography/MR Imaging System

  2010cited by this paper
• Preoperative staging of lung cancer with combined PET-CT.

  2009cited by this paper
• Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT

  2009cited by this paper
• [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning

  2009cited by this paper
• Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data

  2009cited by this paper
• [11C]Choline PET/CT for Targeted Salvage Lymph Node Dissection in Patients with Biochemical Recurrence after Primary Curative Therapy for Prostate Cancer

  2008cited by this paper
• The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

  2008cited by this paper
• Simultaneous in vivo positron emission tomography and magnetic resonance imaging

  2008cited by this paper
• Quantitative PET Imaging of VEGF Receptor Expression

  2008cited by this paper
• Simultaneous PET-MRI: a new approach for functional and morphological imaging

  2008cited by this paper
• Simultaneous MR/PET imaging of the human brain: feasibility study.

  2008cited by this paper
• MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration

  2008cited by this paper
• Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.

  2007cited by this paper
• Can PET–CT with FDG replace contrast enhanced CT for imaging of liver metastases?

  2007cited by this paper
• Revised response criteria for malignant lymphoma.

  2007cited by this paper
• Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

  2007cited by this paper
• Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B

  2007cited by this paper
• F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy

  2007cited by this paper
• Gastrointestinal tract malignancies and positron emission tomography: an overview.

  2006cited by this paper
• PET of vascular endothelial growth factor receptor expression.

  2006cited by this paper
• Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.

  2006cited by this paper
• F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.

  2006cited by this paper
• Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI.

  2006cited by this paper
• Restaging of recurrent cervical carcinoma with dual‐phase [18F]fluoro‐2‐deoxy‐D‐glucose positron emission tomography

  2004cited by this paper
• Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

  2003cited by this paper
• Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.

  2003cited by this paper
• F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma

  2001cited by this paper
• FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.

  2001cited by this paper
• Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

  2000cited by this paper
• Two‐point Dixon technique for water‐fat signal decomposition with B0 inhomogeneity correction

  1997cited by this paper
• A direct comparison of PET activation and electrocortical stimulation mapping for language localization

  1997cited by this paper
• Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1

  year unknowncited by this paper

• Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI

  2023cites this paper
• Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients.

  2021cites this paper
• The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review

  2015cites this paper
• PET-MRI: clinical application of the new hybrid technology

  2015cites this paper
• Non-[18F]FDG tracers on PET-MRI: a pictorial review of oncological applications

  2014cites this paper
• Clinical and research applications of simultaneous positron emission tomography and MRI.

  2014cites this paper
• Potential Pediatric Applications of PET/MR

  2014cites this paper
• Evaluation of Neuroendocrine Liver Metastases: A Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography

  2014influential citation
• Functional magnetic resonance imaging in oncology: state of the art*

  2014cites this paper
• Whole-body-MR-diffusion weighted imaging in oncology.

  2013cites this paper
• Magnetresonanztomografie bei Kindern in Sedierung – anästhesiologisches Prozedere, Zeitbedarf und Determinanten verzögerter Prozessabläufe

  2013cites this paper
• Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Hybrid 18F-FDG PET/MRI in Non-Small Cell Lung Cancer (NSCLC) Lesions: Initial Results

  2013cites this paper
• [Anesthesiological time requirements and reasons for delayed processes in MRI examinations of children undergoing sedation or general anesthesia].

  2013cites this paper
• Diffusion Tensor Imaging of Skeletal Muscle – Correlation of Fractional Anisotropy to Muscle Power

  2013cites this paper